chr19:11071501-11190102 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
Myocardial Infarction |
intron |
0.000354 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11072610 |
rs11879293 |
SMARCA4 |
LDL lipoproteins |
intron |
7.54e-05 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11084994 |
rs12610607 |
SMARCA4 |
Eosinophil counts |
intron |
5e-05 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11092139 |
rs11669133 |
SMARCA4 |
Coronary heart disease |
intron |
1e-08 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11136315 |
rs2075022 |
SMARCA4 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
1.38e-06 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11140144 |
rs4804561 |
SMARCA4 |
Eosinophil counts |
intron |
2.4e-05 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11159096 |
rs12052201 |
SMARCA4 |
Multiple complex diseases |
intron |
0.000777 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11159525 |
rs12052058 |
SMARCA4 |
Multiple complex diseases |
intron |
0.000762 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Coronary Artery Disease |
intron |
0.000614 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Lipid levels |
intron |
4.52e-08 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Lipoprotein-associated phospholipase A2 activity and mass |
intron |
6.74e-05 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Cardiovascular disease risk factors |
intron |
3.06e-06 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Soluble ICAM-1 |
intron |
1.1e-10 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
Cholesterol, total |
intron |
3.39e-11 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163562 |
rs1529729 |
SMARCA4 |
LDL cholesterol |
intron |
5.64e-11 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Type 2 diabetes |
intron |
0.000794 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Multiple complex diseases |
intron |
0.00044 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Myocardial infarction (early onset) |
intron |
2e-09 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Cardiovascular disease risk factors |
intron |
3.18e-05 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron |
2e-09 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary heart disease |
intron |
1e-09 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Pericardial fat |
intron |
9.73e-10 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) age >50 |
intron |
7e-07 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
LDL cholesterol |
intron |
1.24e-33 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) age <=50 |
intron |
2.7e-09 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease (CAD) (males) |
intron |
4.52e-10 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Cholesterol, total |
intron |
4.59e-26 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease with myocardial infarction |
intron |
5.39e-08 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease or large artery stroke |
intron |
2e-11 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease |
intron |
3e-11 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11163601 |
rs1122608 |
SMARCA4 |
Coronary artery disease or ischemic stroke |
intron |
3e-12 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11177408 |
rs10415811 |
NA |
Coronary heart disease |
NA |
0.00072 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11179709 |
rs73013202 |
NA |
Coronary heart disease |
NA |
7.15e-07 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11185919 |
rs10423733 |
NA |
Metabolite levels |
NA |
2.65e-11 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11188117 |
rs55997232 |
NA |
Metabolite levels |
NA |
2e-12 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11188153 |
rs55791371 |
NA |
Lipid metabolism phenotypes |
NA |
8e-17 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11188164 |
rs56125973 |
NA |
Metabolite levels |
NA |
4.97e-16 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11188247 |
rs56289821 |
NA |
Metabolite levels |
NA |
1.07e-10 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11189620 |
rs189596789 |
NA |
Menopause (age at onset) |
NA |
4.98e-08 |
GWASdb |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-26 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11100236 |
rs2228671 |
LDLR |
LDL cholesterol |
synonymous_variant |
4e-14 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11100236 |
rs2228671 |
LDLR |
Cholesterol, total |
synonymous_variant |
9e-24 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11084354 |
rs11668477 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
2e-07 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
2e-26 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11116650 |
rs2738446 |
LDLR |
Metabolite levels |
intron_variant |
2e-12 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Carotid intima media thickness |
intron_variant |
1e-07 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Cardiovascular disease risk factors |
intron_variant |
5e-11 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipoprotein-associated phospholipase A2 activity and mass |
intron_variant |
3e-11 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-117 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Cholesterol, total |
intron_variant |
7e-97 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11127797 |
rs2738459 |
LDLR |
LDL cholesterol |
intron_variant |
7e-06 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Lipid metabolism phenotypes |
intergenic_variant |
8e-17 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Metabolite levels |
intron_variant |
4e-09 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
5e-25 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
3e-18 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
1e-25 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Lipid metabolism phenotypes |
intron_variant |
2e-31 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Abdominal aortic aneurysm |
intron_variant |
2e-10 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
3e-115 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11089332 |
rs17249141 |
SMARCA4 - LDLR |
LDL cholesterol |
upstream_gene_variant |
2e-17 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
4e-262 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Cholesterol, total |
intron_variant |
5e-202 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11145500 |
rs4804146 |
SPC24 |
Lipid traits |
3_prime_UTR_variant |
7e-06 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
2e-51 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
LDL cholesterol |
intron_variant |
7e-08 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11077571 |
rs56289821 |
SMARCA4 - LDLR |
Coronary artery disease |
intergenic_variant |
4e-15 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11139463 |
rs7258950 |
LDLR - SPC24 |
LDL cholesterol |
intron_variant |
1e-24 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11139463 |
rs7258950 |
LDLR - SPC24 |
Cholesterol, total |
intron_variant |
2e-16 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
Cholesterol, total |
intergenic_variant |
2e-113 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11078223 |
rs112374545 |
SMARCA4 - LDLR |
LDL cholesterol |
intergenic_variant |
7e-142 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11077477 |
rs55791371 |
SMARCA4 - LDLR |
Myocardial infarction |
intergenic_variant |
3e-08 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11091630 |
rs6511720 |
LDLR |
Abdominal aortic aneurysm |
intron_variant |
8e-14 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11079976 |
rs142130958 |
SMARCA4 - LDLR |
Metabolite levels (lipoprotein measures) |
intergenic_variant |
7e-47 |
GWAS_Catalog |
| chr19:11071501-11190102 |
chr19:11189689 |
rs138534124 |
KANK2 |
Cholesterol, total |
intron_variant |
8e-09 |
GWAS_Catalog |